Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Antioxidants (Basel, Switzerland)|June 2, 2021
Keap1/Nrf2 Signaling PathwayGerasimos P Sykiotis
Hormones (Athens, Greece)|December 5, 2024
A short review of current knowledge regarding long-term treatment of Graves' disease with antithyroid drugsIlaria Giordani, Gerasimos P Sykiotis
Science Signaling|March 11, 2010
Stress-activated cap'n'collar transcription factors in aging and human diseaseGerasimos P Sykiotis, Dirk Bohmann
Developmental Cell|January 16, 2008
Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in DrosophilaGerasimos P Sykiotis, Dirk Bohmann
Hormones (Athens, Greece)|November 18, 2006
Molecular mechanisms of transcriptional regulation by nuclear receptors. Perspectives for therapeutic implicationsGerasimos P Sykiotis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|May 31, 2006
Apoptosis: the suicide solution in cancer treatment and chemopreventionGerasimos P Sykiotis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|February 17, 2007
Targeting the nerve growth factor network in Alzheimer's diseaseGerasimos P Sykiotis, Athanasios G Papavassiliou
Disease Models & Mechanisms|July 2, 2011
Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's diseaseMaria Cecilia Barone, Gerasimos P Sykiotis, Dirk Bohmann
Minerva Endocrinologica|September 27, 2017
Endocrine and neuroendocrine cytopathologyMassimo Bongiovanni, Stefano La Rosa, Gerasimos P Sykiotis
Frontiers in Nuclear Medicine|October 2, 2024
Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case ReportNathalie Rouiller, Marie Nicod Lalonde, Gerasimos P Sykiotis
Pageof 10